MedPath

Evaluation of a Physical Activity Referral Scheme

Not Applicable
Completed
Conditions
Cardiovascular Risk Factor
Musculoskeletal Injury
Cardiovascular Diseases
Cancer
Physical Activity
Depression
Diabetes Mellitus, Type 2
Obesity
Metabolic Syndrome
Anxiety
Interventions
Behavioral: Usual care exercise referral scheme
Behavioral: Physical activity referral scheme
Registration Number
NCT03490747
Lead Sponsor
Paula Watson
Brief Summary

The study will evaluate the effectiveness of a co-developed exercise referral scheme. Participants will be recruited to one of three groups 1. Co-developed exercise referral scheme, 2. Usual care exercise referral scheme, 3. No treatment control (no intervention). The study will measure effectiveness by observing change in cardiorespiratory fitness at 12 weeks. Intervention cost-effectiveness will also be evaluated at 3 months follow-up using objective physical activity data.

Detailed Description

Evidence of effectiveness for UK exercise referral is unclear. This representation has been deemed an unfair assessment of its potential to impact public health. This is due to systematic review evidence that reports evaluations of exercise referral interventions that are not evidence-based or underpinned by behaviour change theory.

This evaluation is the third phase of a project that aims to co-develop (Phase 1), pilot (phase 2) and evaluate (phase 3) an evidence-based exercise referral scheme. This approach is underpinned by the Medical Research Council guidance for complex interventions.

Through co-development work with a multidisciplinary group of researchers and local stakeholders and subsequent pilot work, it is hypothesised that the co-developed, evidence-based intervention will have improved chances of implementation success, and therefore, clinical effectiveness.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
68
Inclusion Criteria

• 18 years or older and have a health-related risk factor (e.g. high blood pressure, hyperglycaemia, obesity etc.) or a health condition (diabetes, cardiovascular disease, anxiety, depression etc.) that may be alleviated by increasing current PA levels.

Exclusion Criteria
  • Uncontrolled health-conditions (Cardiac, metabolic, respiratory etc.) and/or any recent traumatic events (e.g. myocardial infarction).
  • Unstable angina or aortic stenosis.
  • Severe psychological or neurological conditions.
  • Participation in an ERS at any location other than the research centres (at the time of recruitment).

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Usual care referral schemeUsual care exercise referral schemeComparative, usual care exercise referral scheme.
Co-developed referral schemePhysical activity referral schemeA physical activity referral scheme co-developed by multidisciplinary stakeholders to incorporate behaviour change support and ensure pragmatic relevance and feasibility.
Primary Outcome Measures
NameTimeMethod
Change in cardiorespiratory fitnessBaseline and week 12.

Estimated via the Astrand-Rhyming cycle protocol using the updated age and sex specific nomogram.

Secondary Outcome Measures
NameTimeMethod
Change in psychological wellbeingBaseline, week 12, and 6 months.

Psychological wellbeing will be measured using the Warwick-Edinburgh Mental Well-being Scale (WEMWBS, Tennant et al., 2007). WEMWBS is a 14-item positively worded instrument containing items related to psychological functioning (e.g. "I've been thinking clearly") and subjective well-being (e.g. "I've been feeling cheerful"). Participants are asked to rate on a Likert scale of 1 (none of the time) to 5 (all of the time) how well each statement describes their experiences over the last two weeks.

Change in objective physical activity levelsBaseline, week 12, and 6 months

Objective physical activity levels will be analysed using a hip worn accelerometer (ActiGraph GT3X). 7-day monitoring periods will recorded at three time points. During the 7-day monitoring period, each participant will complete a diary to record hours of use and to distinguish between work and leisure hours.

Change in triglyceridesBaseline and week 12.

A 15ml blood sample will be taken. Blood profiles will be analysed as a measure of cardiometabolic health. Analysis will be conducted at LJMU. Patients will be made aware of the storage and use of their tissue.

Change in total cholesterolBaseline and week 12.

A 15ml blood sample will be taken. Blood profiles will be analysed as a measure of cardiometabolic health. Analysis will be conducted at LJMU. Patients will be made aware of the storage and use of their tissue.

Change in plasma glucoseBaseline and week 12.

A 15ml blood sample will be taken. Blood profiles will be analysed as a measure of cardiometabolic health. Analysis will be conducted at LJMU. Patients will be made aware of the storage and use of their tissue.

Change in flow-mediated dilationBaseline and week 12.

Endothelium dependent vasodilatation of the brachial arteries will be examined using ultrasound. Brachial artery baseline diameter and blood flow will be assessed in one arm. An ultrasound probe is placed on the bicep for 1 minute before a blood pressure cuff (placed around the forearm) is inflated to suprasystolic pressure (\~220 mmHg) for 5 minutes. Immediately after the cuff is deflated, changes in arterial diameter and flow will be assessed continuously for 3 minutes using the ultrasound probe. Ultrasound data will then be analysed post hoc.

Attendance at consultationsWeek 1, 4, 8, 12, and 18

Patient attendance records will be collected by ERPs at the following time-points:

* Intervention centre: 1, 4,8,12 and 18 weeks;

* Usual care centre: 1 and 12 weeks.

Attendance at fitness centreWeek 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12. Months 4, 5 and 6

The number of times patients sign in at the fitness centre to go to either the gym or a class will be recorded on a weekly basis for weeks 1 to 12, then on a monthly basis up to 6 months. This information is automatically recorded at fitness centres when patients visit.

Fidelity - consultation attendanceWeek 18

ERPs from both intervention and usual care centres will be asked to monitor the number of consultations offered (measured by appointment bookings or records of appointments offered but declined by participants), and the number of consultations conducted for each patient.

Change in carotid vasoreactivityBaseline and week 12.

The carotid vasoreactivity (cold pressor) test will measure the carotid artery's response to a stimulus. Similar to the flow-mediated dilation procedure, an ultrasound probe will be placed on the patient's left side of their neck, positioned in such a way to allow a clear image of the right common carotid artery to be displayed on the ultrasound monitor screen. The cold pressor procedure involves submersion of the left hand to wrist in ice slush for 180-seconds. Ultrasound data will then be analysed post hoc.

Fidelity - consultation communication strategiesWeek 1, 4, 8, 12, and 18

A random sample of ERS inductions from both intervention and usual care centres (approx 10 per centre) plus a random sample of 4, 8, 12 and 18-week consultations from the intervention centre only will be audio-recorded and coded for the use of "needs-supportive" communication strategies (using a coding manual developed through a previous pilot study (REF 16/WA/0231)). In addition, all intervention centre recordings will be coded for fidelity to an agreed protocol, e.g. asking required questions about physical activity, setting an action plan, giving out patient log book etc.

Change in health-related quality of life measureBaseline, week 12, and 6 months.

Participants' change in health-related quality of life (HRQoL) will be measured at baseline, 12 weeks, and 6 months. The EQ-5D will be used, this is a validated tool for measuring HRQoL. This tool has been applied successfully in a recent UK trial-based economic evaluation of exercise referral schemes (Edwards et al. 2013).

Loss in revenue costsWeek 18

Captured via telephone interview with fitness centre manager and/or coordinators (questions have been used in previous research).

Change in self-reported physical activityBaseline, week 12, and 6 months.

Patients' perceived physical activity levels will be recorded with the short version of the International Physical Activity Questionnaire (IPAQ, Craig et al., 2003). The short-IPAQ is a 7-day recall self-administered tool that measures intensity, frequency and duration of physical activity and provides a total estimate of energy expenditure. A total score of MET-minutes/day/week and sedentary behaviour minutes/day/week will be calculated according to the IPAQ scoring protocol.

Change in patient health care utilisation costsBaseline and 6 months

Captured via questionnaire (questions adapted from validated questionnaire).

Intervention operating and set up costsWeek 18

Captured via telephone interview with Exercise Referral Scheme Personnel from (organisation e.g. local authority/ fitness centre/ research institute; questions adapted from validated questionnaire).

Change in patient costsBaseline, Week 12 and 6 months

Captured via patient questionnaire during lab testing (questions adapted from validated questionnaire).

Trial Locations

Locations (1)

Liverpool John Moores University

🇬🇧

Liverpool, Merseyside, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath